Sinocare Inc
SZSE:300298

Watchlist Manager
Sinocare Inc Logo
Sinocare Inc
SZSE:300298
Watchlist
Price: 25.82 CNY -1.22% Market Closed
Market Cap: 14.6B CNY
Have any thoughts about
Sinocare Inc?
Write Note

Sinocare Inc
Investor Relations

Nestled in the heart of China's burgeoning biotech industry, Sinocare Inc. has steadily transformed itself into a powerhouse in the realm of glucose monitoring and diabetes management. Founded in 2002, the company was driven by an urgent need to address the growing epidemic of diabetes in China and beyond. As diabetes continued to exact a heavy toll both economically and medically, Sinocare sought to leverage advanced technological innovations to pioneer user-friendly and affordable monitoring solutions. By placing a firm emphasis on research and development, the company sharpened its expertise in biosensing technology, allowing it to produce a comprehensive range of glucose monitors, test strips, and related healthcare products that cater not just to hospitals but also empower individuals with diabetes to manage their conditions effectively.

In its journey, Sinocare smartly diversified beyond simple diagnostics into broader health management solutions. With an eye on increasing the accessibility and functionality of their products, they pursued strategic alliances and acquisitions, notably acquiring Nipro diagnostic business (now Trividia Health) and PTS Diagnostics. These moves helped broaden Sinocare’s horizons to international markets, offering it a stronger footing in the lucrative U.S. and European markets in addition to its dominant Asian presence. Sinocare makes money through the sale of its monitoring devices and the recurring revenue stream generated by test strips and other consumables. Their integrated approach, combining product sales with digital health management services, helps in building a robust ecosystem around its core offerings. This innovative business model not only boosts their bottom line but positions Sinocare as a critical player in the global fight against diabetes, continuously driving towards a future where chronic disease management is much more convenient and effective.

Show more

Earnings Calls

No Earnings Calls Available

Management

Mr. Shao Bo Li
Chairman & GM
No Bio Available
Mr. Jianwen Cai
Deputy General Manager
No Bio Available
Mr. Baishen Ouyang
Chairman of the Supervisory Board & Assistant to the GM
No Bio Available
Mr. Chungeng Chen
Supervisor & Supply Chain Director
No Bio Available

Contacts

Address
HUNAN
Changsha
No. 265 Guyuan Road, High-Tech Industrial Development Zone
Contacts
+8673189935529
www.sinocare.com